Telomerasas: funciones en el ciclo celular y perspectivas de aplicación en el tratamiento del cáncer
Palabras clave:
telómero, telomerasa, ciclo celular, telomere, telomerase, cellular cycleResumen
Recientemente, se ha estudiado el comportamiento de las enzimas en células cancerosas y sus posibles aplicaciones diagnósticas y terapéuticas. En busca de la caracterización de la estructura, el mecanismo de acción y la regulación de una de ellas, la telomerasa, así como sus potencialidades en el tratamiento de las enfermedades proliferativas, se desarrolla esta consulta bibliográfica de 41 artículos científicos sobre el tema. En ella se reafirma el llamado a la comunidad científica mundial a que retome este importante campo de investigación, debido a la corroboración de que las telomerasas participan en la inmortalidad de las células cancerosas, por lo que pueden constituir una alternativa viable en el desarrollo de terapéuticas orientadas al tratamiento de patologías celulares ploriferativas
ABSTRACT
Recently, the behavior of these enzymes has been studied in cancerous cells and its diagnostic and therapeutic possible applications. With the objective of characterizing the structure, the action mechanism and the regulation of the telomerases as well as their potentialities in the treatment of the proliferative illnesses, a bibliographical consultation of 41 scientific articles was developed. telomerases participate in the immortality of the cancerous cells and they constitute an alternative in the development of therapies guided toward the treatment of proliferative cellular pathologies, what justifies the necessity to make a call to the scientific world community so that it recaptures this important investigation field
Citas
2. Pierce B. Genética. Un enfoque conceptual (2da Edición). México: Editorial Médica Panamericana; 2009.
3. Klug W. Conceptos de Genética (8va Edición). New York: Editorial Pearson Prentice Hall; 2009.
4. Zakian VA. Telomeres beginning to understand the end. Science. 1995;270:1601-7.
5. Witzany G. The viral origins of Telomeres and Telomerase and their important role in Eukaryogenesis and Genome Mainteinance. Biosemiotics 1; 2009.
6. Viria V, Morris DK, Lundblad V. Est 1 has the properties of a single-stranded telomere end-binding protein. Genes Dev. 1996;10:3094-104.
7. Chong L, Stensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P, et al. A human telomeric protein. Science. 1995;270:1663-7.
8. Smith S, Lange T. TRF1, a mammalian telomeric protein. Trends Genet. 1997;13:21-6.
9. Pommier JP, Lebeau J, Ducray C, Sabatier L. Chromosomal instability and alteration of telomere repeat sequence. Biochimic. 1995;77:817-25.
10. Kirk KE, Harmon BP, Reichardt IK, Sedat JW, Blackburn EH. Block in znaphase chromosome separation caused by telomerase template mutation. Science. 1997;275:1478-81.
11. Chiu CP, Harley CB. Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc Soc Exp Biol Med. 1997;214:99-106.
12. Counter CM. The roles of telomeres and telomerase in cell life span. Mutat Res. 1996;366:45-63.
13. Wright WE, Piatyszeck MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 1996;18:173-9.
14. Hsiao R, Sharma HW, Ramakrishnan S, Keith E, Narayanan R. Telomerase activity in normal human endothelial cells. Anticancer Res. 2010;17:827-32.
15. Saito T, Scheneider A, Martel N, Mizumoto H, Bulgay-Moeschel M, Kudo R, et al. Proliferation-associated regulation of telomerase activity in human endometrium and its potencial implication in early cancer diagnosis. Biochem Biophys Res Commun. 1997;321:610-4.
16. Weng N, Levine BL, June CH, Hodes RJ. Regulation of telomerase RNA template expression in human T lumphocyute development and activation. J Immunol.. 1997;158:3215-20.
17. Igarashi H, Sakagushi N. Telomerase activity is induced in human peripheral B lumphocytes by the stimulation to antigen receptor. Blood. 1997;89:1299-307.
18. Tofgard R. Mainteance of the chromosomes by telomeres and the enzime telomerase. The Nobel Assembly at Karolinska Institute; 2009.
19. Cooper JP, Nimmo ER, Alishire RC, Cech TR. Regulation of telomeric lenght and function by a myb-domain protein in fission yeast. Nature. 1997;385:744-7.
20. Collins K. Structure and function of telomerase. Curr Opin Cell Biol. 1996;8:374-80. 5.
21. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell. 1997;88:875-84.
22. Lendva TS, Morris DK, Sah J, Balasubramanian B, Lundblad V. Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics. 1996;144:1399-412.
23. Masutomi K. Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component. J Biol Chem. 2011; 275: 22568-73.
24. Shimada Y, Nakano M, Kanda N, Murakami-Murofushi K, Kim JK, Ide T, et al. Cycle-dependent activation of telomerase in naturally synchronized culture of a true slime mold, Physarum polycephalum. Biochem Biophys Res Commun. 1997;232:4921-6.
25. Rufer AL. Tumor specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Oncogene. 2009;16: 979-83 .
26. Alon B. Of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells. Mol Ther. 2012;2:539-44.
27. Recal K. Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships. J Med Chem. 2009; 42: 4538-46.
28. Chiv CP. Inhibition of telomerase activity by ribozimes in endometrial carcinoma cells. Cancer Research; 2009.
29. Yokoyama Y. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Res. 2010; 58: 5406-10.
30. Smith S. Tankyrase, a poly (ADP-ribose) polymerase at human telomeres. Science. 2012; 282: 1484-87.
31. Battachay A, Blackburn EH. A functional telomerase RNA swap in vivo reveals the importance of nontemplate RNA domains. Proc Natl Acad Sci. 1997;94:2823-7.
32. Hayflick L, Moorhead PS. The serial cultivation of human diploid cells. 2010. Available from: http: //www.cogforlife.org/HayflickExpCell.pdf (2010/01/26)
33. Nawaz S, Hashizumi TL, Markkhan NE, Shroyer AL, Shroyer KR. Telomerase expression in human breast cancer with and without lumph node metastases. Am J Clin Pathol. 1997;107:542-7.
34. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, Kubota Y. Telomerase activity in primary prostate cancer. J Urol. 1997;157:1161-5.
35. Sallinen P, Miettinen H, Sallinen SL, Haapasalo H, Helin H, Kononen J. Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am J Pathol. 1997;150:1159-64.
36. Shay JW, Gazdar AF. Telomerase in the early detection of cancer. J Clin Pathol. 2002;50:106-9.
37. Castelo P, Choufani S, Mack S, Gallagher D, Zhang C, Lipman, et al. Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. Lancet Oncol. 2013; 14(6): 534-42.
38. Meyerson M. Telomerase enzime activation and human cell immortalization. Toxicology Letters. 2010: 102-03.
39. Li Y, Ye F, Lü WG, Zeng WJ, Wei LH, Xie X. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings. Int J Gynecol Cancer. 2010; 20(4): 631-7.
40. Su LY, Li XL, Shen L, Zhang Y, Zhao MM, Yin ZH, et al.Polymorphisms of TERT and CLPTM1L and the risk of hepatocellular carcinoma in Chinese males. Asian Pac J Cancer Prev. 2014;15(19):8197-201.
41. Li H, Fu J, Xiu Y, Zhou Q. Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion. Zhongguo Fei Ai Za Zhi. 2010; 13(6): 652-4.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará bajo una Licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional (CC BY-NC 4.0)
Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o servidores preprint) siempre que se indique la publicación inicial en esta revista.
Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada.
